Nishio et al. [34,35] reported studies of phenylureas 28 and 29 as DDR kinase inhibitors with potential uses in cancer treatment; 28 had an IC50 of 4.2 nM for inhibition of DDR1. The gene discussed is DDR1; the disease is cancer.